Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Lanièce Delaunay C, Martínez-Baz I, Sève N, Domegan L, Mazagatos C, Buda S, Meijer A, Kislaya I, Pascu C, Carnahan A, Oroszi B, Ilić M, Maurel M, Melo A, Sandonis Martín V, Trobajo-Sanmartín C, Enouf V, McKenna A, Pérez-Gimeno G, Goerlitz L, de Lange M, Rodrigues AP, Lazar M, Latorre-Margalef N, Túri G, Castilla J, Falchi A, Bennett C, Gallardo V, Dürrwald R, Eggink D, Guiomar R, Popescu R, Riess M, Horváth JK, Casado I, García MDC, Hooiveld M, Machado A, Bacci S, Kaczmarek M, Kissling E; European Primary Care Vaccine Effectiveness Group. Lanièce Delaunay C, et al. Among authors: carnahan a. Euro Surveill. 2024 Mar;29(13):2300403. doi: 10.2807/1560-7917.ES.2024.29.13.2300403. Euro Surveill. 2024. PMID: 38551095 Free PMC article.
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study.
Kissling E, Pozo F, Martínez-Baz I, Buda S, Vilcu AM, Domegan L, Mazagatos C, Dijkstra F, Latorre-Margalef N, Kurečić Filipović S, Machado A, Lazar M, Casado I, Dürrwald R, van der Werf S, O'Donnell J, Linares Dopido JA, Meijer A, Riess M, Višekruna Vučina V, Rodrigues AP, Mihai ME, Castilla J, Goerlitz L, Falchi A, Connell J, Castrillejo D, Hooiveld M, Carnahan A, Ilić M, Guiomar R, Ivanciuc A, Maurel M, Omokanye A, Valenciano M; I-MOVE study team. Kissling E, et al. Among authors: carnahan a. Influenza Other Respir Viruses. 2023 Jan;17(1):e13069. doi: 10.1111/irv.13069. Epub 2022 Nov 21. Influenza Other Respir Viruses. 2023. PMID: 36702797 Free PMC article.
Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe.
Broberg E, Melidou A, Prosenc K, Bragstad K, Hungnes O; WHO European Region and the European Influenza Surveillance Network members of the reporting countries. Broberg E, et al. Euro Surveill. 2016;21(13). doi: 10.2807/1560-7917.ES.2016.21.13.30184. Euro Surveill. 2016. PMID: 27074657 Free article.
Absence of association between 2019-20 influenza vaccination and COVID-19: Results of the European I-MOVE-COVID-19 primary care project, March-August 2020.
Kissling E, Hooiveld M, Brytting M, Vilcu AM, de Lange M, Martínez-Baz I, Sigerson D, Enkirch T, Belhillil S, Meijer A, Castilla J, William N, Carnahan A, Falchi A, Hendriksen J, Casado I, Murray J, Enouf V, Dijkstra F, Marques DFP, Valenciano M. Kissling E, et al. Among authors: carnahan a. Influenza Other Respir Viruses. 2021 Jul;15(4):429-438. doi: 10.1111/irv.12839. Epub 2021 Jan 22. Influenza Other Respir Viruses. 2021. PMID: 33481344 Free PMC article.
Spotlight influenza: The 2019/20 influenza season and the impact of COVID-19 on influenza surveillance in the WHO European Region.
Adlhoch C, Sneiderman M, Martinuka O, Melidou A, Bundle N, Fielding J, Olsen SJ, Penttinen P, Pastore L, Pebody R; European Influenza Surveillance Network; Members of the European Influenza Surveillance Network. Adlhoch C, et al. Euro Surveill. 2021 Oct;26(40):2100077. doi: 10.2807/1560-7917.ES.2021.26.40.2100077. Euro Surveill. 2021. PMID: 34622760 Free PMC article.
Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.
Adlhoch C, Delgado-Sanz C, Carnahan A, Larrauri A, Popovici O, Bossuyt N, Thomas I, Kynčl J, Slezak P, Brytting M, Guiomar R, Redlberger-Fritz M, Maistre Melillo J, Melillo T, van Gageldonk-Lafeber AB, Marbus SD, O'Donnell J, Domegan L, Gomes Dias J, Olsen SJ. Adlhoch C, et al. Among authors: carnahan a. Euro Surveill. 2023 Jan;28(4):2200340. doi: 10.2807/1560-7917.ES.2023.28.4.2200340. Euro Surveill. 2023. PMID: 36700868 Free PMC article.
Co-circulation of influenza A(H1N1)pdm09 and influenza A(H3N2) viruses, World Health Organization (WHO) European Region, October 2018 to February 2019.
Segaloff H, Melidou A, Adlhoch C, Pereyaslov D, Robesyn E, Penttinen P, Olsen SJ, Region WE; European Influenza Surveillance Network; WHO European Region and European Influenza Surveillance Network. Segaloff H, et al. Euro Surveill. 2019 Feb;24(9):1900125. doi: 10.2807/1560-7917.ES.2019.24.9.1900125. Euro Surveill. 2019. PMID: 30862331 Free PMC article.
A comparison of COVID-19 incidence rates across six European countries in 2021.
Padget M, Adam P, Dorfmuller M, Blondel C, Campos-Matos I, Fayad M, Mateo-Urdiales A, Mesher D, Pistol A, Rebolledo J, Riccardo F, Riess M, Rusu LC, Che D, Coignard B; COVID-19 Study group; COVID-19 Study Group members. Padget M, et al. Euro Surveill. 2023 Oct;28(40):2300088. doi: 10.2807/1560-7917.ES.2023.28.40.2300088. Euro Surveill. 2023. PMID: 37796443 Free PMC article.
52 results